Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328119314> ?p ?o ?g. }
- W4328119314 endingPage "5908" @default.
- W4328119314 startingPage "5908" @default.
- W4328119314 abstract "Computational approaches in immune-oncology therapies focus on using data-driven methods to identify potential immune targets and develop novel drug candidates. In particular, the search for PD-1/PD-L1 immune checkpoint inhibitors (ICIs) has enlivened the field, leveraging the use of cheminformatics and bioinformatics tools to analyze large datasets of molecules, gene expression and protein-protein interactions. Up to now, there is still an unmet clinical need for improved ICIs and reliable predictive biomarkers. In this review, we highlight the computational methodologies applied to discovering and developing PD-1/PD-L1 ICIs for improved cancer immunotherapies with a greater focus in the last five years. The use of computer-aided drug design structure- and ligand-based virtual screening processes, molecular docking, homology modeling and molecular dynamics simulations methodologies essential for successful drug discovery campaigns focusing on antibodies, peptides or small-molecule ICIs are addressed. A list of recent databases and web tools used in the context of cancer and immunotherapy has been compilated and made available, namely regarding a general scope, cancer and immunology. In summary, computational approaches have become valuable tools for discovering and developing ICIs. Despite significant progress, there is still a need for improved ICIs and biomarkers, and recent databases and web tools have been compiled to aid in this pursuit." @default.
- W4328119314 created "2023-03-22" @default.
- W4328119314 creator A5009428613 @default.
- W4328119314 creator A5055639768 @default.
- W4328119314 creator A5056300585 @default.
- W4328119314 creator A5077857761 @default.
- W4328119314 creator A5090457672 @default.
- W4328119314 date "2023-03-21" @default.
- W4328119314 modified "2023-10-01" @default.
- W4328119314 title "Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors" @default.
- W4328119314 cites W1749548564 @default.
- W4328119314 cites W1985213868 @default.
- W4328119314 cites W1987507232 @default.
- W4328119314 cites W1990161102 @default.
- W4328119314 cites W2012034410 @default.
- W4328119314 cites W2016193168 @default.
- W4328119314 cites W2043398720 @default.
- W4328119314 cites W2044200527 @default.
- W4328119314 cites W2056169996 @default.
- W4328119314 cites W2096525273 @default.
- W4328119314 cites W2101375662 @default.
- W4328119314 cites W2103017472 @default.
- W4328119314 cites W2107158607 @default.
- W4328119314 cites W2112411768 @default.
- W4328119314 cites W2118258530 @default.
- W4328119314 cites W2125732073 @default.
- W4328119314 cites W2128016314 @default.
- W4328119314 cites W2128601422 @default.
- W4328119314 cites W2130410032 @default.
- W4328119314 cites W2132629607 @default.
- W4328119314 cites W2149441684 @default.
- W4328119314 cites W2151572058 @default.
- W4328119314 cites W2162579416 @default.
- W4328119314 cites W2171599819 @default.
- W4328119314 cites W2221713243 @default.
- W4328119314 cites W2263839430 @default.
- W4328119314 cites W2279201083 @default.
- W4328119314 cites W2304327826 @default.
- W4328119314 cites W2338150527 @default.
- W4328119314 cites W2375821550 @default.
- W4328119314 cites W2444690946 @default.
- W4328119314 cites W2509892577 @default.
- W4328119314 cites W2521492299 @default.
- W4328119314 cites W2557399158 @default.
- W4328119314 cites W2559588208 @default.
- W4328119314 cites W2607129810 @default.
- W4328119314 cites W2611425558 @default.
- W4328119314 cites W2613978126 @default.
- W4328119314 cites W2625296602 @default.
- W4328119314 cites W2743893844 @default.
- W4328119314 cites W2765224588 @default.
- W4328119314 cites W2765774350 @default.
- W4328119314 cites W2787091682 @default.
- W4328119314 cites W2795686629 @default.
- W4328119314 cites W2801790772 @default.
- W4328119314 cites W2807362308 @default.
- W4328119314 cites W2887293266 @default.
- W4328119314 cites W2898210859 @default.
- W4328119314 cites W2898784124 @default.
- W4328119314 cites W2900127803 @default.
- W4328119314 cites W2901527454 @default.
- W4328119314 cites W2919975879 @default.
- W4328119314 cites W2936472469 @default.
- W4328119314 cites W2937441321 @default.
- W4328119314 cites W2944959599 @default.
- W4328119314 cites W2953065444 @default.
- W4328119314 cites W2965921152 @default.
- W4328119314 cites W2970240468 @default.
- W4328119314 cites W2979330275 @default.
- W4328119314 cites W2985115330 @default.
- W4328119314 cites W2989327573 @default.
- W4328119314 cites W3009188653 @default.
- W4328119314 cites W3042389276 @default.
- W4328119314 cites W3042567488 @default.
- W4328119314 cites W3044163929 @default.
- W4328119314 cites W3087624166 @default.
- W4328119314 cites W3093868212 @default.
- W4328119314 cites W3094967361 @default.
- W4328119314 cites W3095583226 @default.
- W4328119314 cites W3097052776 @default.
- W4328119314 cites W3102147110 @default.
- W4328119314 cites W3106005610 @default.
- W4328119314 cites W3107527779 @default.
- W4328119314 cites W3116337208 @default.
- W4328119314 cites W3133859624 @default.
- W4328119314 cites W3134602841 @default.
- W4328119314 cites W3138101668 @default.
- W4328119314 cites W3139461687 @default.
- W4328119314 cites W3158200825 @default.
- W4328119314 cites W3159554921 @default.
- W4328119314 cites W3164010111 @default.
- W4328119314 cites W3168254371 @default.
- W4328119314 cites W3171496698 @default.
- W4328119314 cites W3172913451 @default.
- W4328119314 cites W3176204074 @default.
- W4328119314 cites W3177828909 @default.
- W4328119314 cites W3182055317 @default.
- W4328119314 cites W3183367489 @default.